{"name":"GamaMabs Pharma","slug":"gamamabs-pharma","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"GM102","genericName":"GM102","slug":"gm102","indication":"Other","status":"phase_2"},{"name":"GM102 expansion","genericName":"GM102 expansion","slug":"gm102-expansion","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"GM102","genericName":"GM102","slug":"gm102","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"GM102 expansion","genericName":"GM102 expansion","slug":"gm102-expansion","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxNR1hKbmhoNzNOUFAtMlZXMXhIcGdQcnRvZDNjQkswZWJTSVd4Rm5XY0t4WmxjR3VNbVZkZjB2My1NX0ZvZUxVS200cHNVVnZjdEZaR3Zmb2hxUzVMc2lJNjdpLVFQZjNhSmZZT3lrbng1THZ5TlFsbk9lcHM3NGx2X1BNMUxCUW9UQVR2UjVoNlItYmlJVnhFWEdXRmUyZlAtSHgtU0FZV2lzWk9lTXNib2xiSG04SFhDTWdHclZuRk1MMVJ5dlJ6Y3RTUkVfdw?oc=5","date":"2024-03-03","type":"pipeline","source":"BioProcess International","summary":"PDB-Dimer Payloads for Antibody Drug Conjugates: A Robust Approach to cGMP Production - BioProcess International","headline":"PDB-Dimer Payloads for Antibody Drug Conjugates: A Robust Approach to cGMP Production","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxQXzBPMUxsVURxbjR6aFBrd0NWRy11X0xNTDd4cmt5OWR0QTJpaVlhNkx4ZUhHaHVaaDRHcFloekdnd1AxeFp6Z05Qb0FzNzRvSjdKMG5pVzVNTFl5Z05xeVRBZE5fN3VCYTJaN1NhS3RQN2pIOE1TOVRnX0VnTThGazN4US1qTU5hUTRoNDg1dS1vWDZwNTcwYWpOLW56VTZD?oc=5","date":"2021-06-07","type":"pipeline","source":"Fierce Biotech","summary":"Elevation files for $100M IPO to fund tumor-agnostic candidate - Fierce Biotech","headline":"Elevation files for $100M IPO to fund tumor-agnostic candidate","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxNZGlKNDEyOTNFOVp1NDJlZTdaaVJxTVpCem5oRmp4OVdjZ2RBUmcxQXdEUUt4RUw3T0MwYWhLT1M0Yk0yM0Ryb3R6VGJVQ3JreHR6TXptME5wdlZOb1NnYW9aaU9SMlE0VGNGZDZvaG5GN19VR3dLeHVHNlJiVExvamRmbGZ2elgtSlJ2MlptVzM4UkdiUURTQ1FyYWtvdkk?oc=5","date":"2021-05-04","type":"deal","source":"Contract Pharma","summary":"Exelixis Acquires GamaMabs Oncology Antibody Program - Contract Pharma","headline":"Exelixis Acquires GamaMabs Oncology Antibody Program","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":2},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}